Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

News Daily News

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Michael O'Riordan

October 27, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Podcast TCTMD Talking Points

Episode 30: PARTNER 2 Quality of Life

September 20, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Daily News

TAVR in the US: Regional Variations in Numbers, Outcomes

Michael O'Riordan

August 22, 2017

Podcast TCTMD Talking Points

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

August 02, 2017

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

News Daily News

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

Michael O'Riordan

July 10, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

News Conference News TVT 2017

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Michael O'Riordan

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

Presentation TVT 2017

The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs

Presenter: Robert O. Bonow, Martin B. Leon, Michael J. Mack

June 15, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Perfect Timing? Afternoon Valve Surgeries Have Fewer Complications

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Episode 30: PARTNER 2 Quality of Life

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

TAVR in the US: Regional Variations in Numbers, Outcomes

Episode 26: PARTNER 1 5-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After TAVR in High-Risk Aortic Stenosis

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

FDA Expands CoreValve Indication to Include Intermediate-Risk Patients

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

The Rationale and Need for a Tiered National System of Valve Centers Controversies and Proposed Programs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content